GlassScriptPhysician profile
Andrew Massar
NPI 1205506748
$2,209.84
in general payments reported to CMS, 2019-2025
32 companies · $479 in 2025
The $479 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $48.36 · 2022: $172 · 2023: $900 · 2024: $610 · 2025: $479.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,446 · Education: $544.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,445.68 |
| Education | $543.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $460.80 | 2023-2025 | Xtandi, Veozah |
| Boston Scientific Corporation | $225.48 | 2023-2024 | |
| Janssen Biotech, INC. | $183.23 | 2023-2025 | Erleada, Akeega, Carvykti |
| Teleflex LLC | $169.06 | 2023-2025 | Urolift |
| Laborie Medical Technologies Corp. | $117.57 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Seagen INC. | $99.99 | 2025 | |
| Endo USA, INC. | $93.22 | 2024-2025 | Xiaflex, Aveed |
| Ferring Pharmaceuticals INC. | $87.78 | 2022-2024 | Adstiladrin |
| Tolmar, INC. | $67.85 | 2023-2024 | |
| Myriad Genetic Laboratories, INC. | $56.83 | 2023-2024 | Prolaris |
| Abbvie INC. | $55.28 | 2022-2024 | |
| Sumitomo Pharma America, INC. | $53.54 | 2025 | Orgovyx |
| Ucb, INC. | $50.86 | 2022 | |
| Antares Pharma, INC. | $44.49 | 2024-2025 | Xyosted |
| Coloplast Corp | $41.18 | 2024 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $40.84 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $34.06 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $33.80 | 2021 | |
| Melinta Therapeutics, LLC | $31.06 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $28.64 | 2023 | Pylarify |
| Urogen Pharma, INC. | $28.22 | 2025 | |
| Accord Healthcare, INC. | $23.33 | 2024 | |
| Novartis Pharmaceuticals Corporation | $22.25 | 2024 | |
| 180 Medical, INC. | $22.05 | 2024 | Cure Catheter |
| Procept Biorobotics Corporation | $21.85 | 2024 | Aquabeam System |
| Axonics, INC. | $20.76 | 2023 | Axonics |
| Pfizer INC. | $19.71 | 2024 | |
| Halozyme INC | $19.50 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.06 | 2023 | Spiriva Respimat, Stiolto Respimat |
| Medtronic, INC. | $14.11 | 2023 | Interstim |
| Janssen Pharmaceuticals, INC | $13.51 | 2022 | |
| Penumbra, INC. | $11.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Massar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.